Journals / Türk Geriatri Dergisi / 2019 / Cilt: 22 - Sayı: 3

GERIATRIC BELL’S PALSY; RISK FACTORS AND LABORATORY RESULTS

GERİATRİK BELL PARALİZİSİ; RİSK FAKTÖRLERİ VE LABORATUVAR SONUÇLARI

Pages
269–275
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, a significant correlation was observed between the initial grade of facialparalysis and neutrophil-to-lymphocyte ratio upon admission, which can be considered as aprognostic factor.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Idiopathic facial paralysis or Bell’s palsy is the most common type ofperipheral facial paralysis.
📊
Key Findings & Data:Advanced age and systemic diseases, such as diabetes andhypertension are considered as negative prognostic factors for Bell’s palsy still controversial.Here, we aimed to compare the epidemiologic features and prognostic factors of patients withBell’s palsy aged ≥65 years.Materials and Method: Records of patients with Bell’s palsy (age, ≥65 years) who wereadmitted to our clinic between January 2008 and December 2017 were evaluated.Results: We included 89 (72.4%) patients with Bell’s palsy.
💡
Conclusion & Impact:In addition, a significant correlation was observed between the initial grade of facialparalysis and neutrophil-to-lymphocyte ratio upon admission, which can be considered as aprognostic factor.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Idiopathic facial paralysis or Bell’s palsy is the most common type ofperipheral facial paralysis. Advanced age and systemic diseases, such as diabetes andhypertension are considered as negative prognostic factors for Bell’s palsy still controversial.Here, we aimed to compare the epidemiologic features and prognostic factors of patients withBell’s palsy aged ≥65 years.Materials and Method: Records of patients with Bell’s palsy (age, ≥65 years) who wereadmitted to our clinic between January 2008 and December 2017 were evaluated.Results: We included 89 (72.4%) patients with Bell’s palsy. The patients’ ages variedbetween 65 and 91 (72.70 ± 5.9) years. Paralysis was in the right side in 59.6% (n = 53) and in theleft side in 40.4% (n = 36) of the patients. Three (3.4%) patients had progressive facial paralysis.One (1.1%) had positive family history. After at least 6 months of follow-up, 71 (79.8%), 10(11.2%), 6 (6.7%), and 2 (2.25%) patients were diagnosed with grade 1 and 2, 3, 4, and 5 Bell’spalsy, respectively. Furthermore, a statistically significant correlation was observed betweenthe initial paralysis grade and neutrophil-to-lymphocyte ratio (p=0.001).Conclusion: Although old age is considered as a negative prognostic factor in patientswith BP, we observed satisfactory recovery rates in geriatric patients who received appropriatetreatment. In addition, a significant correlation was observed between the initial grade of facialparalysis and neutrophil-to-lymphocyte ratio upon admission, which can be considered as aprognostic factor.

Özet

Giriş: İdiopatik fasiyal paralizi ya da Bell paralizisi (BP) tüm yaş gruplarında görülebilen göreceli olarak sık bir durumdur. Farklı çalışmalarda ileri yaş, diyabet, hipertansiyon gibi eşlik eden sistemik hastalıklar BP’de kötü prognostik faktör olarak belirtilmesine rağmen bu konular hala tartışmalıdır. Bu çalışmamızda 65 yaş ve üstü BP tanısı almış hastalarda epidemiyolojik özellikler ve prognostik faktörler incelendi. Gereç ve Yöntem: Ocak 2008-Aralık 2017 tarihleri arasında, paralizi sonrası en az 6. ay kontrolleri olan BP tanısı ile tedavi ve takip edilen altmış beş yaş ve üstü hastaların dosyaları retrospektif olarak tarandı. Bulgular: Çalışmaya BP tanılı 89 hasta dahil edildi. Hastaların yaşları 65 ile 91 arasında (72.70±5.9) idi. Paralizilerin sağ tarafta görülme oranı % 59.6 (n=53); sol tarafta % 40.4 (n=36) idi. Üç (%3.4) olguda progresif fasiyal paralizi saptandı. Bir (%1.1) olguda aile anamnezi pozitifti. En az altı aylık takip sonunda 71 hasta (%79.8) evre 1-2, 10 hasta (%11.2) evre 3, 6 hasta (%6.7) evre 4, 2 hasta (%2.25) evre 5 olarak saptandı. Başvuru evresi yüksekliği ile Nötrofil Lenfosit Oranı (NLO) arasındaki ilişki anlamlı saptandı (p=0.001). Sonuç: BP prognozunda ileri yaş negative bir prognostik faktör olarak kabul edilse de, uygun tedavi ile geriatrik hastalarda tatmin edici iyileşme oranları elde ettik. Ayrıca, prognostik faktör olarak değerlendirilebilecek olan NLO ile başvuru esnasındaki yüksek fasiyal sinir paralizisi derecesi arasında anlamlı bir korelasyon gözlendi.

🔖

Cite This Article

ALTAŞ, E., MÜDERRİS, T., TOKAT, T., AYSEL, A., ERGÜN, U., BOYACIOĞLU, H., YILMAZ, F. (2022). GERIATRIC BELL’S PALSY; RISK FACTORS AND LABORATORY RESULTS. Türk Geriatri Dergisi, Cilt: 22 - Sayı: 3, 269–275. https://ajindex.com/articles/623658

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Zandian A, Osiro S, Hudson R, et al. The neurologist’s dilemma: A comprehensive clinical review of Bell’s palsy, with emphasis on current management trends. Med Sci Monit 2014;20(1):83-90. (PMID: 24441932
  2. Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg 2013;149(1):1-27. (PMID:24189771
  3. Peitersen E. Bell’s palsy: The spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;549(1):4-30. (PMID:12482166
  4. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93(2):146- 7. (PMID:3921901
  5. Tiemstra JD, Khatkhate N. Bell’s palsy: Diagnosis and management. Am Fam Physician 2007;76(1):997-1002. (PMID:17956069
  6. Sullivan FM, Swan IR, Donnan PT, et al. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: The BELLS study. Health Technol Assess 2009;13(1):1- 130. (PMID:19833052
  7. Salinas RA, Alvarez G, Ferreira J. Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst 2004;18;(4):CD001942. (PMID:15495021
  8. Axelsson S, Lindberg S, Stjernquist-Desatnik A. Outcome of treatment with valacyclovir and prednisone in patients with Bell’s palsy. Ann Otol Rhinol Laryngol 2003;112(3):197-201. (PMID:12656408
  9. Yeo SG, Lee YC, Park DC, Cha CI. Acyclovir plus steroid vs steroid alone in the treatment of Bell’s palsy. Am J Otolaryngol 2008;29(3):163-166. (PMID:18439948
  10. Lee HY, Byun JY, Park MS, Yeo SG. Effect of Aging on the Prognosis of Bell’s Palsy. Otol Neurotol 2013;34(4):766-770. (PMID:23370572
  11. Devriese PP, Schumacher T, Scheide A, De Jongh RH, Houtkooper JM. Incidence, prognosis and recovery of Bell’s palsy. A survey of about 1000 patients. Clin Otolaryngol Allied Sci 1990;15(1):15-27. (PMID:2323075
  12. Bayındır T, Tan M, Selimoğlu E. Diagnosis and Management of Bell Palsy. KBB Forum 2011;10(1):18- 30. http://kbb-forum.net/journal/uploads/pdf/pdf_ KBB_263.pdf 13. Riga M, Kefalidis G, Danielides V. The role of diabetes mellitus in the clinical presentation and prognosis of Bell palsy. J Am Board Fam Med 2012;25(1):819-826. (PMID:23136321
  13. Valença MM, Valença LP, Lima MC. Idiopathic facial paralysis (Bell’s palsy): A study of 180 patients. Arq Neuropsiquiatr 2001;59(1):733-739. (PMID:11593275
  14. Bosco D, Plastino M, Bosco F, et al. Bell’s palsy: A manifestation of prediabetes? Acta Neurol Scand 2011;123(1